Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14365/5417
Title: | Prevalence and Severity of Central Sensitization in Post‑Polio Syndrome: Associations with Clinical Measures and Quality of Life | Authors: | On, A.Y. Latifoglou, E. Çınar, E. Tanıgör, G. |
Keywords: | Central sensitization pain poliomyelitis post‑polio syndrome quality of life poliomyelitis vaccine adult arthralgia Article central nervous system sensitization cohort analysis controlled study cross-sectional study disease assessment drug therapy electromyography fatigue Fatigue Severity Scale human Likert scale major clinical study male middle aged myalgia Nottingham Health Profile numeric rating scale pain paralytic poliomyelitis poliomyelitis postpoliomyelitis syndrome prevalence quality of life self reported impairments in persons with late effects of polio rating scale sleep disorder weakness |
Publisher: | Wolters Kluwer Medknow Publications | Abstract: | Objectives: To investigate the presence and severity of central sensitization (CS) and its associations with clinical measures and quality of life (QoL) in individuals with a history of paralytic poliomyelitis with and without post‑polio syndrome (PPS). Methods: In this cross‑sectional study, we included 98 individuals with a history of poliomyelitis, in whom 82 (83.6%) met the criteria of PPS. We used CS Inventory (CSI) to evaluate the presence and severity of CS. We evaluated the severity of fatigue, pain, polio‑related impairments, and QoL using a Numerical Rating Scale in addition to Fatigue Severity Scale, Self‑reported Impairments in Persons with late effects of Polio rating scale (SIPP), and Nottingham Health Profile (NHP). Results: CS was present in 52.4% of patients with PPS, of which 63% are classified as severe to extreme. Those with CS reported more severe symptoms, more polio‑related impairments, and worse QoL than those without CS. Severity of CS showed significant positive correlations with severity of fatigue, pain, SIPP, and NHP scales in those with PPS. CSI did not indicate CS in any of those without PPS. Conclusion: CS was present in more than half of the individuals with PPS and correlated with more severe pain, fatigue, and more polio‑related impairments, in addition to poorer QoL. These findings suggest that CS may contribute to the clinical picture in a subgroup of individuals with PPS. Thus, identification and appropriate management of CS patients may potentially help alleviate their symptoms and improve their QoL. © 2024 Annals of Indian Academy of Neurology. | URI: | https://doi.org/10.4103/aian.aian_1040_23 https://hdl.handle.net/20.500.14365/5417 |
ISSN: | 0972-2327 |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Show full item record
CORE Recommender
Page view(s)
46
checked on Nov 18, 2024
Download(s)
4
checked on Nov 18, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.